Status:
COMPLETED
Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Chemotherapy Effect
G-CHOP Chemotherapy
Eligibility:
All Genders
18+ years
Brief Summary
Several experiences of multidisciplinary care pathways associating oncologists, pharmacists and nurses have been reported for cancer patients, with positive results on medication management safety, re...
Eligibility Criteria
Inclusion
- Adult patients aged 18 years or older With hematological malignancy at any stage Initiating R-CHOP or G-CHOP chemotherapy Who do not object to participation in the study and use of collected data
Exclusion
- Patients already enrolled in a clinical trial evaluating any drug product
- Patients living in an institution
- Patients protected by law
- Adults subject to a legal protection measure (curatorship, guardianship) (article L1121-8 of the CSP)
- Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care and persons admitted to a health or social establishment (article L1121-6 of the CSP)
Key Trial Info
Start Date :
June 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05350930
Start Date
June 9 2022
End Date
February 15 2023
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Lyon Sud - Hospices Civils de lyon
Pierre-Bénite, France, 69495